| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 25 | 2024 | 3381 | 1.980 |
Why?
|
| Bone Marrow | 21 | 2023 | 2941 | 1.660 |
Why?
|
| Skull | 11 | 2022 | 810 | 1.230 |
Why?
|
| Stem Cell Niche | 8 | 2018 | 342 | 1.220 |
Why?
|
| Microscopy, Confocal | 17 | 2019 | 1969 | 1.170 |
Why?
|
| Pigment Epithelium of Eye | 5 | 2007 | 220 | 1.110 |
Why?
|
| Microscopy, Fluorescence | 14 | 2021 | 2699 | 1.090 |
Why?
|
| Bone Marrow Cells | 15 | 2023 | 2513 | 1.070 |
Why?
|
| Flow Cytometry | 20 | 2019 | 5975 | 1.050 |
Why?
|
| Molecular Imaging | 8 | 2020 | 831 | 1.030 |
Why?
|
| Mesenchymal Stem Cells | 14 | 2016 | 1625 | 1.020 |
Why?
|
| Arterioles | 2 | 2018 | 253 | 1.020 |
Why?
|
| Fluorescent Dyes | 14 | 2021 | 1915 | 0.970 |
Why?
|
| Osteocytes | 4 | 2021 | 197 | 0.960 |
Why?
|
| Cell Tracking | 4 | 2017 | 145 | 0.940 |
Why?
|
| Leukocytes | 5 | 2023 | 2039 | 0.900 |
Why?
|
| Lasers | 7 | 2024 | 952 | 0.870 |
Why?
|
| Luminescent Proteins | 4 | 2016 | 853 | 0.870 |
Why?
|
| Retinal Degeneration | 2 | 2024 | 414 | 0.850 |
Why?
|
| Microtechnology | 1 | 2023 | 72 | 0.850 |
Why?
|
| Neoplastic Cells, Circulating | 8 | 2019 | 933 | 0.830 |
Why?
|
| Single-Cell Analysis | 7 | 2017 | 2183 | 0.730 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 6 | 2018 | 271 | 0.730 |
Why?
|
| Mice | 94 | 2024 | 81045 | 0.710 |
Why?
|
| Green Fluorescent Proteins | 11 | 2019 | 2088 | 0.660 |
Why?
|
| Cell Movement | 24 | 2020 | 5212 | 0.660 |
Why?
|
| Animals | 116 | 2024 | 168561 | 0.630 |
Why?
|
| Staining and Labeling | 6 | 2015 | 1099 | 0.620 |
Why?
|
| Cell Membrane | 4 | 2016 | 3744 | 0.580 |
Why?
|
| Coloring Agents | 2 | 2013 | 565 | 0.570 |
Why?
|
| Hematopoiesis | 8 | 2024 | 2066 | 0.550 |
Why?
|
| Fibrillar Collagens | 1 | 2016 | 41 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 34 | 2022 | 21821 | 0.540 |
Why?
|
| Laser Coagulation | 3 | 2007 | 326 | 0.530 |
Why?
|
| Color | 2 | 2016 | 306 | 0.520 |
Why?
|
| Capillaries | 2 | 2019 | 774 | 0.520 |
Why?
|
| Leukemia | 2 | 2022 | 1507 | 0.520 |
Why?
|
| Retina | 4 | 2023 | 2611 | 0.500 |
Why?
|
| Endothelium, Vascular | 5 | 2023 | 4455 | 0.500 |
Why?
|
| Cell Adhesion | 14 | 2023 | 3139 | 0.490 |
Why?
|
| Clone Cells | 3 | 2019 | 1692 | 0.490 |
Why?
|
| Capillary Permeability | 1 | 2018 | 798 | 0.480 |
Why?
|
| Optics and Photonics | 4 | 2015 | 321 | 0.470 |
Why?
|
| Photochemistry | 1 | 2013 | 238 | 0.450 |
Why?
|
| Cell Lineage | 9 | 2024 | 2504 | 0.430 |
Why?
|
| Bone Marrow Transplantation | 4 | 2017 | 2763 | 0.430 |
Why?
|
| Mice, SCID | 16 | 2019 | 2715 | 0.430 |
Why?
|
| Microscopy | 6 | 2023 | 903 | 0.420 |
Why?
|
| Fluorescence | 5 | 2019 | 751 | 0.390 |
Why?
|
| Cell Count | 4 | 2022 | 1831 | 0.370 |
Why?
|
| Multiple Myeloma | 10 | 2019 | 5169 | 0.370 |
Why?
|
| Mice, Transgenic | 13 | 2021 | 9735 | 0.370 |
Why?
|
| Bone and Bones | 8 | 2021 | 2575 | 0.370 |
Why?
|
| Chemokine CXCL12 | 7 | 2021 | 462 | 0.350 |
Why?
|
| E-Selectin | 6 | 2017 | 579 | 0.340 |
Why?
|
| Mice, Inbred BALB C | 11 | 2012 | 6382 | 0.340 |
Why?
|
| Receptors, CXCR4 | 6 | 2021 | 726 | 0.330 |
Why?
|
| Laser Therapy | 2 | 2007 | 1071 | 0.330 |
Why?
|
| Endothelial Cells | 8 | 2023 | 3455 | 0.320 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3507 | 0.320 |
Why?
|
| Neutrophils | 4 | 2019 | 3711 | 0.320 |
Why?
|
| Arteries | 5 | 2019 | 1118 | 0.320 |
Why?
|
| Contrast Media | 1 | 2021 | 5295 | 0.310 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2015 | 1788 | 0.310 |
Why?
|
| Tryptophan | 1 | 2010 | 478 | 0.310 |
Why?
|
| Skin | 5 | 2021 | 4353 | 0.300 |
Why?
|
| Hemodynamics | 1 | 2018 | 4197 | 0.300 |
Why?
|
| Bone Regeneration | 2 | 2023 | 427 | 0.300 |
Why?
|
| Stem Cells | 7 | 2023 | 3563 | 0.290 |
Why?
|
| Boronic Acids | 2 | 2011 | 965 | 0.290 |
Why?
|
| Selectins | 2 | 2011 | 102 | 0.290 |
Why?
|
| Dexamethasone | 1 | 2014 | 1949 | 0.290 |
Why?
|
| Lenses | 1 | 2007 | 45 | 0.290 |
Why?
|
| Microglia | 2 | 2015 | 1261 | 0.290 |
Why?
|
| Oxygen | 3 | 2020 | 4169 | 0.280 |
Why?
|
| Cell Survival | 11 | 2020 | 5872 | 0.280 |
Why?
|
| Stromal Cells | 8 | 2014 | 1353 | 0.270 |
Why?
|
| Fluorescein Angiography | 2 | 2007 | 936 | 0.270 |
Why?
|
| Antibodies | 3 | 2019 | 2459 | 0.270 |
Why?
|
| Osteoblasts | 3 | 2012 | 1163 | 0.270 |
Why?
|
| Pyrazines | 2 | 2011 | 1231 | 0.260 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2018 | 4029 | 0.260 |
Why?
|
| Venous Thrombosis | 5 | 2015 | 1237 | 0.260 |
Why?
|
| Blood Platelets | 2 | 2015 | 2506 | 0.250 |
Why?
|
| Neoplasm Metastasis | 6 | 2019 | 4839 | 0.250 |
Why?
|
| Acoustics | 1 | 2005 | 239 | 0.240 |
Why?
|
| Cell Differentiation | 13 | 2024 | 11470 | 0.240 |
Why?
|
| Cells, Cultured | 13 | 2017 | 19223 | 0.240 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 5 | 2016 | 495 | 0.230 |
Why?
|
| Graft Survival | 2 | 2011 | 3733 | 0.230 |
Why?
|
| Blood Vessels | 4 | 2016 | 1124 | 0.230 |
Why?
|
| Environment | 1 | 2009 | 1115 | 0.230 |
Why?
|
| Cranial Sutures | 1 | 2023 | 93 | 0.220 |
Why?
|
| Reticulocytes | 1 | 2003 | 290 | 0.220 |
Why?
|
| Molecular Probes | 2 | 2014 | 316 | 0.220 |
Why?
|
| Cell Separation | 7 | 2016 | 1749 | 0.210 |
Why?
|
| Apoptosis | 8 | 2015 | 9715 | 0.210 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2023 | 188 | 0.210 |
Why?
|
| TRPM Cation Channels | 1 | 2023 | 140 | 0.210 |
Why?
|
| Indocyanine Green | 1 | 2003 | 238 | 0.200 |
Why?
|
| Cell Proliferation | 12 | 2023 | 10472 | 0.200 |
Why?
|
| Inflammation | 10 | 2024 | 10578 | 0.200 |
Why?
|
| Endotoxemia | 1 | 2023 | 206 | 0.200 |
Why?
|
| Cell Line, Tumor | 15 | 2021 | 16665 | 0.200 |
Why?
|
| Fibrin | 2 | 2015 | 506 | 0.200 |
Why?
|
| P-Selectin | 3 | 2023 | 600 | 0.190 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 2986 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.190 |
Why?
|
| Zebrafish | 1 | 2011 | 2990 | 0.180 |
Why?
|
| Fracture Healing | 2 | 2014 | 426 | 0.180 |
Why?
|
| Goblet Cells | 1 | 2023 | 287 | 0.180 |
Why?
|
| Aging | 3 | 2023 | 8626 | 0.180 |
Why?
|
| Meningitis, Bacterial | 1 | 2022 | 218 | 0.180 |
Why?
|
| Polyurethanes | 1 | 2020 | 107 | 0.180 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2020 | 125 | 0.180 |
Why?
|
| Splenomegaly | 1 | 2020 | 190 | 0.180 |
Why?
|
| Gene Library | 1 | 2022 | 1076 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 4438 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 1599 | 0.170 |
Why?
|
| Muscle Proteins | 2 | 2022 | 1159 | 0.170 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 5 | 2024 | 647 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2016 | 227 | 0.170 |
Why?
|
| Equipment Failure Analysis | 5 | 2011 | 867 | 0.170 |
Why?
|
| Microcirculation | 1 | 2023 | 1285 | 0.170 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2022 | 3497 | 0.170 |
Why?
|
| Automation | 1 | 2021 | 584 | 0.170 |
Why?
|
| Dendrites | 1 | 2021 | 485 | 0.160 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2018 | 37 | 0.160 |
Why?
|
| Stress, Physiological | 2 | 2018 | 1402 | 0.160 |
Why?
|
| Integrases | 1 | 2021 | 533 | 0.160 |
Why?
|
| Ferric Compounds | 4 | 2012 | 374 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 3 | 2020 | 1350 | 0.160 |
Why?
|
| Carbon | 1 | 2022 | 686 | 0.160 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2019 | 124 | 0.160 |
Why?
|
| Mice, Knockout | 9 | 2024 | 14554 | 0.160 |
Why?
|
| Fucose | 2 | 2016 | 125 | 0.150 |
Why?
|
| Bone Diseases | 1 | 2021 | 416 | 0.150 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 1525 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2021 | 315 | 0.150 |
Why?
|
| Microsurgery | 1 | 2003 | 796 | 0.150 |
Why?
|
| Nanotechnology | 1 | 2003 | 709 | 0.150 |
Why?
|
| Antigens | 1 | 2023 | 1462 | 0.150 |
Why?
|
| Adult Stem Cells | 1 | 2019 | 216 | 0.150 |
Why?
|
| Benzylisoquinolines | 1 | 2016 | 15 | 0.140 |
Why?
|
| Disease Models, Animal | 12 | 2019 | 18006 | 0.140 |
Why?
|
| Interleukin-10 | 2 | 2013 | 1200 | 0.140 |
Why?
|
| Adoptive Transfer | 2 | 2011 | 844 | 0.140 |
Why?
|
| Signal Transduction | 9 | 2021 | 23387 | 0.140 |
Why?
|
| Veins | 3 | 2019 | 769 | 0.140 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 4147 | 0.140 |
Why?
|
| Lactic Acid | 1 | 2022 | 1132 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2011 | 0.140 |
Why?
|
| Pyridinium Compounds | 1 | 2016 | 84 | 0.140 |
Why?
|
| Wnt Proteins | 2 | 2011 | 721 | 0.140 |
Why?
|
| Microspheres | 4 | 2013 | 777 | 0.140 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2011 | 247 | 0.140 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 1586 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2007 | 2921 | 0.140 |
Why?
|
| Scattering, Radiation | 3 | 2007 | 498 | 0.130 |
Why?
|
| Humans | 55 | 2023 | 742088 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1670 | 0.130 |
Why?
|
| Graft vs Host Reaction | 1 | 2015 | 103 | 0.130 |
Why?
|
| Tissue Engineering | 3 | 2020 | 1877 | 0.130 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 4771 | 0.130 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 10163 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2011 | 675 | 0.130 |
Why?
|
| Candidiasis | 1 | 2017 | 365 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.130 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 957 | 0.130 |
Why?
|
| Femoral Vein | 2 | 2012 | 159 | 0.130 |
Why?
|
| Time Factors | 7 | 2021 | 40054 | 0.120 |
Why?
|
| Candida albicans | 1 | 2017 | 394 | 0.120 |
Why?
|
| Photons | 3 | 2014 | 587 | 0.120 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 675 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 653 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2011 | 2502 | 0.120 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2014 | 160 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1296 | 0.120 |
Why?
|
| Hormones | 1 | 2017 | 884 | 0.120 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 3564 | 0.110 |
Why?
|
| Myeloid Cells | 2 | 2010 | 804 | 0.110 |
Why?
|
| Lymph Nodes | 3 | 2021 | 3465 | 0.110 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 225 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2005 | 3678 | 0.110 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 171 | 0.110 |
Why?
|
| HMGB1 Protein | 1 | 2014 | 131 | 0.110 |
Why?
|
| Equipment Design | 5 | 2011 | 3582 | 0.110 |
Why?
|
| Busulfan | 1 | 2014 | 262 | 0.110 |
Why?
|
| Osteogenesis | 3 | 2015 | 1299 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 2186 | 0.110 |
Why?
|
| Retinal Neurons | 1 | 2013 | 65 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 729 | 0.110 |
Why?
|
| Elastin | 1 | 2014 | 305 | 0.110 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 96 | 0.110 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 721 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2017 | 5425 | 0.110 |
Why?
|
| Male | 25 | 2023 | 349538 | 0.110 |
Why?
|
| Nanoparticles | 3 | 2014 | 1902 | 0.110 |
Why?
|
| Limbus Corneae | 1 | 2014 | 142 | 0.110 |
Why?
|
| Fucosyltransferases | 4 | 2017 | 119 | 0.110 |
Why?
|
| Stress, Mechanical | 2 | 2016 | 1684 | 0.110 |
Why?
|
| Polyglactin 910 | 1 | 2012 | 59 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 6 | 2022 | 6313 | 0.110 |
Why?
|
| Graft Rejection | 3 | 2010 | 4393 | 0.110 |
Why?
|
| Guanylate Cyclase | 1 | 2013 | 201 | 0.100 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2011 | 53 | 0.100 |
Why?
|
| Phantoms, Imaging | 6 | 2019 | 2466 | 0.100 |
Why?
|
| Chemotaxis | 3 | 2012 | 607 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 1017 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2004 | 876 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 514 | 0.100 |
Why?
|
| Pericytes | 2 | 2016 | 291 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2013 | 323 | 0.100 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 405 | 0.100 |
Why?
|
| Sensitivity and Specificity | 7 | 2013 | 14720 | 0.100 |
Why?
|
| Plasminogen Activators | 1 | 2012 | 209 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 4379 | 0.100 |
Why?
|
| Neoplasms | 4 | 2017 | 21596 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 1837 | 0.100 |
Why?
|
| Propylene Glycols | 1 | 2011 | 92 | 0.100 |
Why?
|
| Ophthalmoscopy | 2 | 2013 | 176 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 689 | 0.100 |
Why?
|
| Epigenomics | 1 | 2016 | 902 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2017 | 765 | 0.100 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2011 | 91 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 559 | 0.100 |
Why?
|
| Indoles | 3 | 2015 | 1834 | 0.090 |
Why?
|
| Cattle | 2 | 2007 | 3923 | 0.090 |
Why?
|
| Oligopeptides | 2 | 2015 | 1176 | 0.090 |
Why?
|
| Immediate-Early Proteins | 1 | 2013 | 453 | 0.090 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 249 | 0.090 |
Why?
|
| Tomography | 1 | 2012 | 388 | 0.090 |
Why?
|
| Stem Cell Transplantation | 4 | 2014 | 1618 | 0.090 |
Why?
|
| Rabbits | 2 | 2007 | 4886 | 0.090 |
Why?
|
| Thrombosis | 2 | 2015 | 2966 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 2633 | 0.090 |
Why?
|
| Vascular System Injuries | 1 | 2013 | 250 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2915 | 0.090 |
Why?
|
| Regeneration | 2 | 2019 | 1485 | 0.090 |
Why?
|
| Optic Nerve | 1 | 2013 | 548 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 251 | 0.090 |
Why?
|
| Oligosaccharides | 1 | 2011 | 414 | 0.090 |
Why?
|
| Retinal Diseases | 2 | 2007 | 683 | 0.090 |
Why?
|
| Sphingosine | 1 | 2011 | 307 | 0.080 |
Why?
|
| Cicatrix | 1 | 2015 | 761 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2012 | 19862 | 0.080 |
Why?
|
| DNA Damage | 1 | 2019 | 2423 | 0.080 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 36 | 0.080 |
Why?
|
| Memory | 1 | 2019 | 2163 | 0.080 |
Why?
|
| Sepsis | 1 | 2023 | 2589 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2023 | 1155 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2013 | 952 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2017 | 13029 | 0.080 |
Why?
|
| Lighting | 1 | 2011 | 231 | 0.080 |
Why?
|
| Kinetics | 3 | 2019 | 6474 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 867 | 0.080 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 236 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2009 | 241 | 0.080 |
Why?
|
| Female | 23 | 2021 | 379592 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2017 | 8925 | 0.080 |
Why?
|
| Collagen | 2 | 2014 | 2684 | 0.080 |
Why?
|
| Mice, Nude | 4 | 2017 | 3689 | 0.080 |
Why?
|
| Transplants | 1 | 2010 | 208 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 2417 | 0.080 |
Why?
|
| Transplantation Conditioning | 1 | 2014 | 1597 | 0.080 |
Why?
|
| Genetic Engineering | 1 | 2013 | 952 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2009 | 202 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 713 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 721 | 0.070 |
Why?
|
| Endoscopes | 1 | 2008 | 174 | 0.070 |
Why?
|
| Transfection | 5 | 2016 | 5892 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1546 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 183 | 0.070 |
Why?
|
| Macrophages | 3 | 2024 | 5655 | 0.070 |
Why?
|
| Antigens, Ly | 2 | 2019 | 291 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 5519 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1740 | 0.070 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9410 | 0.070 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2013 | 711 | 0.070 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 768 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 1376 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 8425 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2156 | 0.070 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2007 | 204 | 0.070 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 422 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 609 | 0.060 |
Why?
|
| Bone Remodeling | 2 | 2020 | 575 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2011 | 668 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 2077 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 3769 | 0.060 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 960 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2009 | 739 | 0.060 |
Why?
|
| Mice, Inbred NOD | 3 | 2017 | 1875 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2009 | 1470 | 0.060 |
Why?
|
| Particle Size | 2 | 2012 | 1640 | 0.060 |
Why?
|
| Differential Threshold | 1 | 2004 | 80 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2012 | 1538 | 0.060 |
Why?
|
| Coculture Techniques | 3 | 2017 | 1341 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 4414 | 0.060 |
Why?
|
| Cell Communication | 1 | 2011 | 1619 | 0.060 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 2217 | 0.060 |
Why?
|
| Eye Injuries | 1 | 2007 | 245 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2021 | 12164 | 0.060 |
Why?
|
| Air | 1 | 2004 | 181 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 1692 | 0.060 |
Why?
|
| Radiography | 1 | 2015 | 7010 | 0.060 |
Why?
|
| Skin Transplantation | 1 | 2009 | 1074 | 0.060 |
Why?
|
| Glycosylation | 2 | 2017 | 1123 | 0.060 |
Why?
|
| Mitochondria | 1 | 2016 | 3520 | 0.060 |
Why?
|
| Energy Transfer | 1 | 2003 | 109 | 0.060 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 1351 | 0.060 |
Why?
|
| Rhodamines | 1 | 2003 | 183 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 11039 | 0.060 |
Why?
|
| Wound Healing | 1 | 2014 | 2781 | 0.060 |
Why?
|
| NADP | 1 | 2024 | 225 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 791 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 3770 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2016 | 707 | 0.050 |
Why?
|
| Anticoagulants | 2 | 2015 | 4595 | 0.050 |
Why?
|
| Nanotubes | 1 | 2003 | 77 | 0.050 |
Why?
|
| Rats | 5 | 2023 | 24265 | 0.050 |
Why?
|
| Axons | 1 | 2011 | 1681 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2003 | 251 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 2161 | 0.050 |
Why?
|
| Liver | 1 | 2018 | 7470 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6259 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 3067 | 0.050 |
Why?
|
| Cell Death | 1 | 2007 | 1695 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 80 | 0.050 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2022 | 124 | 0.050 |
Why?
|
| Eye | 1 | 2006 | 728 | 0.050 |
Why?
|
| Phlebography | 2 | 2012 | 333 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 319 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2019 | 4211 | 0.050 |
Why?
|
| Temperature | 1 | 2007 | 2207 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2008 | 1051 | 0.050 |
Why?
|
| Sutures | 1 | 2023 | 298 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 12071 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2014 | 5180 | 0.050 |
Why?
|
| Endotoxins | 1 | 2023 | 525 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2009 | 1634 | 0.050 |
Why?
|
| Dextrans | 2 | 2012 | 592 | 0.050 |
Why?
|
| Erythropoiesis | 1 | 2024 | 705 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3239 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 1737 | 0.040 |
Why?
|
| Transplantation, Heterologous | 3 | 2016 | 2382 | 0.040 |
Why?
|
| Immunologic Memory | 2 | 2017 | 1348 | 0.040 |
Why?
|
| Chlorides | 2 | 2012 | 667 | 0.040 |
Why?
|
| PAX7 Transcription Factor | 1 | 2019 | 53 | 0.040 |
Why?
|
| Carbocyanines | 2 | 2014 | 174 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2020 | 1547 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2023 | 969 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2019 | 2085 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2021 | 677 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 2211 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 534 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2023 | 668 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4229 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2017 | 2751 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 2 | 2018 | 1363 | 0.040 |
Why?
|
| Optical Fibers | 1 | 2019 | 138 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2010 | 9274 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35342 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 258 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2007 | 1052 | 0.040 |
Why?
|
| Proteins | 2 | 2011 | 6096 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2021 | 3001 | 0.040 |
Why?
|
| Brain | 3 | 2022 | 26343 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 7988 | 0.040 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2018 | 111 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2018 | 146 | 0.040 |
Why?
|
| Immunocompetence | 1 | 2017 | 137 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2010 | 1827 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2021 | 880 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2023 | 1538 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2021 | 651 | 0.040 |
Why?
|
| Miniaturization | 2 | 2008 | 164 | 0.040 |
Why?
|
| Benzylamines | 2 | 2009 | 226 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2552 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6347 | 0.040 |
Why?
|
| Swine | 2 | 2004 | 5934 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 13655 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2016 | 65 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2021 | 980 | 0.030 |
Why?
|
| Protons | 1 | 2022 | 1126 | 0.030 |
Why?
|
| Calcium | 2 | 2023 | 5753 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2020 | 491 | 0.030 |
Why?
|
| Calcitriol | 1 | 2017 | 298 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3428 | 0.030 |
Why?
|
| Receptor, TIE-2 | 1 | 2016 | 178 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 3076 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2021 | 2003 | 0.030 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2016 | 105 | 0.030 |
Why?
|
| Microvessels | 1 | 2020 | 544 | 0.030 |
Why?
|
| Cell Line | 3 | 2016 | 15994 | 0.030 |
Why?
|
| Perfusion | 1 | 2020 | 1359 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2016 | 154 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2021 | 62966 | 0.030 |
Why?
|
| Ligands | 2 | 2016 | 3293 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2015 | 223 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 1158 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 212 | 0.030 |
Why?
|
| Oscillometry | 1 | 2015 | 147 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 1423 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2016 | 248 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2021 | 3701 | 0.030 |
Why?
|
| Maleimides | 1 | 2015 | 112 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2014 | 103 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2016 | 2500 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2016 | 594 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 300 | 0.030 |
Why?
|
| Static Electricity | 1 | 2014 | 267 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 738 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 436 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 804 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 2015 | 322 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 282 | 0.030 |
Why?
|
| Fractals | 1 | 2014 | 123 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 611 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 20774 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 400 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 2014 | 447 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2009 | 4250 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2014 | 1159 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2009 | 3731 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 437 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 815 | 0.030 |
Why?
|
| Plasma | 1 | 2016 | 575 | 0.030 |
Why?
|
| RNA Interference | 2 | 2011 | 2890 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2013 | 90 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 712 | 0.030 |
Why?
|
| Neointima | 1 | 2013 | 135 | 0.030 |
Why?
|
| Biotechnology | 1 | 2014 | 278 | 0.030 |
Why?
|
| Fetal Development | 1 | 2018 | 767 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 540 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2012 | 225 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 7721 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2011 | 3557 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 2255 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 248 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 451 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 782 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2024 | 2956 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2024 | 3461 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2011 | 32 | 0.030 |
Why?
|
| Tibia | 1 | 2017 | 1075 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 2940 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 879 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1899 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2015 | 5522 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 900 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2012 | 204 | 0.020 |
Why?
|
| Cell Division | 2 | 2009 | 4564 | 0.020 |
Why?
|
| Half-Life | 1 | 2012 | 658 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5163 | 0.020 |
Why?
|
| Algorithms | 3 | 2019 | 13853 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 11690 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2011 | 365 | 0.020 |
Why?
|
| Glycolipids | 1 | 2011 | 205 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2187 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 269 | 0.020 |
Why?
|
| Neurosciences | 1 | 2015 | 347 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9387 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2011 | 122 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2019 | 1771 | 0.020 |
Why?
|
| Disease Progression | 2 | 2021 | 13256 | 0.020 |
Why?
|
| Necrosis | 1 | 2014 | 1643 | 0.020 |
Why?
|
| Cytokines | 1 | 2005 | 7317 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 391 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13019 | 0.020 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 166 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4751 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Immune System | 1 | 2015 | 804 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 1866 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 657 | 0.020 |
Why?
|
| Rats, Inbred WF | 1 | 2009 | 140 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.020 |
Why?
|
| Ribosomal Protein S6 | 1 | 2009 | 70 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2012 | 531 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 1182 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 944 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2011 | 600 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 625 | 0.020 |
Why?
|
| Integrin alpha4beta1 | 1 | 2009 | 121 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2009 | 354 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2016 | 1806 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2016 | 2260 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3127 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2014 | 1121 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 2012 | 3691 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 2027 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2335 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2011 | 692 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3618 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11363 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2009 | 1161 | 0.020 |
Why?
|
| Adult | 4 | 2023 | 213712 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 906 | 0.020 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2008 | 177 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1780 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2013 | 1274 | 0.020 |
Why?
|
| Heparin | 1 | 2014 | 1636 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 1254 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 1860 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2007 | 162 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3199 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 1438 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 2009 | 553 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2006 | 75 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2009 | 627 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3612 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5095 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2005 | 41 | 0.020 |
Why?
|
| Mineral Oil | 1 | 2005 | 25 | 0.020 |
Why?
|
| Spleen | 1 | 2012 | 2359 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3574 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 501 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1728 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 1799 | 0.020 |
Why?
|
| Laminin | 1 | 2007 | 418 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 1683 | 0.020 |
Why?
|
| Computer Systems | 1 | 2007 | 483 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 1119 | 0.020 |
Why?
|
| Fibronectins | 1 | 2009 | 723 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2010 | 907 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 774 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3862 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9581 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 1562 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2015 | 2723 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 1284 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2013 | 2452 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2842 | 0.010 |
Why?
|
| Diffusion | 1 | 2005 | 832 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2007 | 834 | 0.010 |
Why?
|
| CHO Cells | 1 | 2006 | 1407 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 1000 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 2014 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1581 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1911 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2170 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1606 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2593 | 0.010 |
Why?
|
| Cricetinae | 1 | 2006 | 2471 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2440 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 2107 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6608 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1185 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2938 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2007 | 1961 | 0.010 |
Why?
|
| Cathepsins | 1 | 2002 | 239 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 2133 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18112 | 0.010 |
Why?
|
| Epitopes | 1 | 2008 | 2569 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5238 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 2637 | 0.010 |
Why?
|
| Prognosis | 2 | 2012 | 29010 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3444 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1525 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3504 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20086 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 2370 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 926 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7873 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2038 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 5705 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2924 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4465 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2011 | 5019 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8300 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 25575 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29717 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6756 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12773 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 8436 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15530 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85649 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 9826 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21719 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 213127 | 0.000 |
Why?
|